FI930577A - VACCIN OCH BEHANDLINGSMETOD FOER HIV-INFEKTION - Google Patents

VACCIN OCH BEHANDLINGSMETOD FOER HIV-INFEKTION Download PDF

Info

Publication number
FI930577A
FI930577A FI930577A FI930577A FI930577A FI 930577 A FI930577 A FI 930577A FI 930577 A FI930577 A FI 930577A FI 930577 A FI930577 A FI 930577A FI 930577 A FI930577 A FI 930577A
Authority
FI
Finland
Prior art keywords
behandlingsmetod
infektion
vaccin
foer
hiv
Prior art date
Application number
FI930577A
Other languages
Finnish (fi)
Other versions
FI930577A0 (en
Inventor
Gale E Smith
Franklin Volvovitz
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Publication of FI930577A0 publication Critical patent/FI930577A0/en
Publication of FI930577A publication Critical patent/FI930577A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
FI930577A 1991-06-11 1993-02-10 VACCIN OCH BEHANDLINGSMETOD FOER HIV-INFEKTION FI930577A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71415291A 1991-06-11 1991-06-11
PCT/US1992/004980 WO1992022654A1 (en) 1991-06-11 1992-06-10 Vaccine and treatment method of human immunodeficiency virus infection

Publications (2)

Publication Number Publication Date
FI930577A0 FI930577A0 (en) 1993-02-10
FI930577A true FI930577A (en) 1993-03-24

Family

ID=24868938

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930577A FI930577A (en) 1991-06-11 1993-02-10 VACCIN OCH BEHANDLINGSMETOD FOER HIV-INFEKTION

Country Status (18)

Country Link
EP (1) EP0542998A1 (en)
JP (1) JPH06501851A (en)
CN (1) CN1068266A (en)
AU (2) AU2193192A (en)
BG (1) BG97519A (en)
CA (1) CA2087732A1 (en)
EE (1) EE9400183A (en)
FI (1) FI930577A (en)
HU (1) HUT68355A (en)
IE (1) IE921875A1 (en)
IL (1) IL102092A (en)
LT (1) LT3365B (en)
MX (1) MX9202781A (en)
PL (1) PL297849A1 (en)
PT (1) PT100584A (en)
SK (1) SK18993A3 (en)
WO (1) WO1992022654A1 (en)
ZA (1) ZA924150B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40786E1 (en) * 1984-03-16 2009-06-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US6017536A (en) * 1993-06-07 2000-01-25 Trimeris, Inc. Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
AU1377395A (en) * 1993-12-23 1995-07-10 University Technologies International Inc. Methods of expressing proteins in insect cells and methods of killing insects
JPH11507632A (en) 1995-06-07 1999-07-06 トリメリス，インコーポレーテッド Treatment of HIV and other viral infections using combination therapy
US6395541B1 (en) 1996-05-23 2002-05-28 The Rockefeller University Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6077662A (en) * 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6214540B1 (en) 1997-03-26 2001-04-10 University Of Maryland Biotechnology Institute Chemokines that inhibit immunodeficiency virus infection and methods based thereon
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US6548631B1 (en) 1997-09-16 2003-04-15 BIOMéRIEUX, INC. Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
US6750008B1 (en) 1999-07-09 2004-06-15 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6623741B1 (en) 2000-02-29 2003-09-23 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
CA2505583C (en) 2002-12-03 2014-07-15 University Of Massachusetts Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
EP1692516B1 (en) 2003-10-24 2010-12-01 Immunaid Pty Ltd Method of therapy
PA8809601A1 (en) 2007-12-24 2009-07-23 Cipla Ltd ANTI-RETROVIRAL COMBINATION
EP2982978A1 (en) 2009-05-27 2016-02-10 Immunaid Pty Ltd Methods of treating diseases
KR101655964B1 (en) * 2011-08-19 2016-09-08 임모탈 스피릿 리미티드 Antibody and antibody-containing composition
CN102961760B (en) * 2011-09-01 2017-07-18 常州文松生物技术有限公司 Overlapping peptide is used as reagent and its application for preparing Skin-test and detection specific cellular immunity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1

Also Published As

Publication number Publication date
CA2087732A1 (en) 1992-12-12
IL102092A (en) 1996-11-14
LTIP335A (en) 1995-01-31
EP0542998A1 (en) 1993-05-26
ZA924150B (en) 1993-02-24
AU4028895A (en) 1996-02-22
IL102092A0 (en) 1993-01-14
HUT68355A (en) 1995-06-28
CN1068266A (en) 1993-01-27
JPH06501851A (en) 1994-03-03
IE921875A1 (en) 1992-12-16
EE9400183A (en) 1995-12-15
WO1992022654A1 (en) 1992-12-23
FI930577A0 (en) 1993-02-10
AU2193192A (en) 1993-01-12
SK18993A3 (en) 1993-10-06
BG97519A (en) 1994-03-24
HU9300686D0 (en) 1993-06-28
PT100584A (en) 1993-07-30
MX9202781A (en) 1993-04-01
LT3365B (en) 1995-07-25
PL297849A1 (en) 1994-01-24

Similar Documents

Publication Publication Date Title
FI934668A (en) TILLSLUTNINGSSYTEM FOER OEVERTAECKTA KAERL OCH LIKNANDE
FI934078A (en) HAORVAORDSKOMPOSITIONER INNEHAOLLANDE FORMGIVNINGS / KONDITIONERINGS-MEDEL OCH MJUKGOERINGSMEDEL
FI925427A (en) Styrkrets och foerfarande Foer transmissionsutgaong
FI934897A (en) SYRAMODIFIERADE POLYHYDRISKA ALKOHOLHHTSTSTERKLIBBMEDEL OCH VAERMESMAELTBARAKOMPOSITIONER INNEHAOLLANDE DESSA KLIBBMEDEL
FI925533A0 (en) TANTAL- ELLER NIOBBASERAD PEROVSKIT OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV
FI924747A (en) PEG-IMIDAT OCH PROTEINDERIVAT DAERAV
FI930577A0 (en) VACCIN OCH BEHANDLINGSMETOD FOER HIV-INFEKTION
FI88744B (en) FOERFARANDE OCH ANORDNING FOER REGLERING AV BERGBORRNING
FI921096A (en) EXISTING POLE-DIFFERENTIAL MALEINSYRAANHYDRIDMODIFIERADE ETENPOLYMERER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI912760A (en) SKIVFILTER OCH FILTERELEMENT FOER SKIVFILTER
FI934328A0 (en) FOERFARANDE OCH ANORDNING FOER NQR-TESTNING
FI933799A (en) FOERBAETTRAD HAORBORTTAGNINGSAPPARAT MED ROTERBART HUVUD OCH FLERA FJAEDRAR
FI922920A (en) SEPARATIONSFOERFARANDE OCH ANORDNING HAERFOER
FI921741A (en) EN CATALYTICS OCH BELAEGGNINGSKOMPOSITION INNEHAOLLANDE DENSAMMA
FI934187A0 (en) ICKE-FOERVRAENGDA POLYETENSKUMSTRUKTURER OCH FRAMSTAELLNINGSFOERFARANDE
FI934325A0 (en) INSEKTICID KOMPOSITION OCH INSEKTICIDA ENHETER
FI933359A (en) FODERTILLSATSAEMNE OCH FOERFARANDE
FI924083A (en) SPAENNINGSDEVIATIONKOMPENSATOR FOER SLAECKTID FOER VAEXELRIKTARE OCH OMFORMARE
FI923562A (en) VATTENLOESLIGA HARTSBASERADE BELAEGGNINGAR OCH BLAECK
FI923606A (en) AUTOMATISK OMSLAGSAVLAEGSNINGSMASKIN OCH FOERFARANDE
FI924767A0 (en) ALKYLERINGSFOERFARANDE FOER ISOALKAN-OLEFINER OCH KATALYSATORER FOER DETSAMMA
FI922230A (en) OEVRE AENDPLUGG OCH GRIPANORDNING FOER STAONG MED DELLAENGD
FI925857A (en) NYTT KONSERVERINGSSYSTEM OCH KOMPOSITION AENDAMAOLSENLIG FOER KONSERVERING
FI923147A (en) ELEKTRISK KONTAKTMATARANORDNING FOERSEDD MED EN FRIKTIONSDEL OCH EN DYLIK ANORDNINGS FRAMSTAELLNINGSFOERFARANDE
FI88938B (en) FOERFARANDE OCH ANORDNING FOER SKAERPNING AV YTAN FOER TRAESLIPSMASKINENS SLIPSTEN

Legal Events

Date Code Title Description
FD Application lapsed